Funded K99/R00 Grants
The K99/R00 Pathway to Independence Award in Cancer Research is for outstanding junior scientists in laboratory-based cancer research who are committed to developing research programs in understanding human biology and human disease as they relate to the etiology, pathogenesis, prevention, diagnosis, and treatment of human cancer. This award provides support for a period of one or two years in a mentored environment, followed by a transition to the equivalent of an independent, tenure-track faculty position to develop an independent research program. The K99 provides support for up to 2 years for salary (up to $100,000 plus fringe benefits, per year) and research development support (up to $30,000 per year) during the mentored phase, while the R00 provides up to 3 years of support for the independent phase (up to $249,000 total cost, per year). The K99/R00 requires a minimum of 9 person-months (75% total professional effort) commitment toward the research and career development objectives of the award. Grant applications must include proposals for both phases and the K99/R00 is nonrenewable.
See the NCI Funded Research Portfolio for a current list of K99/R00 awards.
See the List of Intramural K99 awardees below:
NCI Awarded NIH Intramural K99's
Goli Samimi, PhD
Characterization of Stromal-Epithelial Interactions in Ovarian Tumors.
Fengyi Wan, PhD
Novel Subunit of NF-kB Confers Gene Regulatory Specificity
Zhu Wenge, PhD
DNA Replication Control and Its Application to Selective Killing of Cancer Cells
Christina Annunziata, MD, PhD
Characterization of I-kappaB kinase epsilon as an oncogene in ovarian cancer
Qiou Wei, PhD
The Role of Sulfiredoxin in Tumorigenesis and Cancer Progression.
(Ricia) Katherine Hyde, PhD
Analysis of initiating events in inv(16) associated acute myeloid leukemia
Samuel Bunting, PhD
Targeted therapies to correct genomic instability in Brca1-deficient cells.
Jeremy A. Daniel, PhD
Mechanism and specificity of PTIP complex function in B lymphocytes
Stephanie K. Watkins, PhD
Reversing Tolerogenicity of Tumor Associated Dendritic Cells to Enhance CTL Anti-Tumor Immunity in Prostate Cancer
An NIH intramural K99/R00 awardee does not receive K99 funds. The awardee only receives R00 funds when successfully transitioned to an independent position at an extramural institution.